Market revenue in 2023 | USD 387.2 million |
Market revenue in 2030 | USD 521.2 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Kits & Reagents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Lateral Flow Readers |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche, Bio-Rad Laboratories Inc, BioMerieux SA, QuidelOrtho Corp, Hologic Inc, PerkinElmer, Merck KGaA, BD, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lateral flow assays market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 68.72% in 2023. Horizon Databook has segmented the Japan lateral flow assays market based on kits & reagents, lateral flow readers covering the revenue growth of each sub-segment from 2018 to 2030.
Increased collaborations among market entrants are anticipated to boost market growth during the forecast period. For instance, in July 2019, Chembio Diagnostics collaborated with Shire Human Genetic Therapies, Inc. to develop a new diagnostic test.
This is a blood test to detect biomarkers or substances that show an infection or disease in the body. Shire is a subsidiary of Takeda Pharmaceuticals; and therefore, this project would be funded by Takeda. Similar collaborations among market entrants to develop new diagnostic tests are anticipated to fuel the market during the forecast period.
Increase in investments from private organizations to develop diagnostic tests is expected to boost market growth during the forecast period. For instance, in September 2018, the Global Health Innovative Technology Fund announced an investment of USD 3.8 million in Japan’s Fujifilm Corporation based as well as Switzerland’s Foundation for Innovative New Diagnostics to develop a highly sensitive rapid diagnostic test TB-LAM for detection of tuberculosis (TB).
Horizon Databook provides a detailed overview of country-level data and insights on the Japan lateral flow assays market , including forecasts for subscribers. This country databook contains high-level insights into Japan lateral flow assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account